天工國際(00826.HK)擬1.09億元收購偉建工具全部股權
格隆匯 11 月 13日丨天工國際(00826.HK)公佈,於2020年11月13日,天工工具(公司的全資附屬公司,作為買方)訂立股權轉讓協議,據此,天工工具將向駿發及乾嘉投資收購偉建工具的全部股權,總代價為人民幣1.09億元。
公告稱,公司與偉建工具已建立長期業務關係。自2015年以來,公司一直為偉建工具若干原材料的供應商。在與偉建工具多年的業務合作中,董事對偉建工具的業務有深入瞭解。此外,為配合集團透過垂直整合進行擴張的策略,董事相信,通過消除競爭,轉讓事項將創造集團與偉建工具之間的協同效應。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.